Hsu‐Tso Ho

1.3k total citations
17 papers, 935 citations indexed

About

Hsu‐Tso Ho is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Hsu‐Tso Ho has authored 17 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Hsu‐Tso Ho's work include Biochemical and Molecular Research (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Hsu‐Tso Ho is often cited by papers focused on Biochemical and Molecular Research (7 papers), HIV/AIDS drug development and treatment (7 papers) and HIV Research and Treatment (5 papers). Hsu‐Tso Ho collaborates with scholars based in United States, Germany and Sweden. Hsu‐Tso Ho's co-authors include Paul Falk, Joanne J. Bronson, James G. Robertson, Ann W. Walsh, Perry A. Frey, John P. Richard, Kerry M. Ervin, Michael J. M. Hitchcock, William E. Harte and Stanley V. D’Andrea and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Virology.

In The Last Decade

Hsu‐Tso Ho

17 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsu‐Tso Ho United States 15 370 326 293 250 120 17 935
Kristina Bäckbro Sweden 13 374 1.0× 420 1.3× 138 0.5× 209 0.8× 133 1.1× 19 793
Kathleen M. Frey United States 19 362 1.0× 429 1.3× 186 0.6× 183 0.7× 174 1.4× 38 882
Pornwaratt Niyomrattanakit Singapore 16 809 2.2× 677 2.1× 195 0.7× 122 0.5× 410 3.4× 20 1.5k
Richard J. Stern United States 9 175 0.5× 383 1.2× 228 0.8× 53 0.2× 198 1.6× 10 611
J. Kevin Judice United States 14 338 0.9× 411 1.3× 257 0.9× 63 0.3× 132 1.1× 16 919
Irvin Winkler Germany 18 375 1.0× 251 0.8× 155 0.5× 318 1.3× 197 1.6× 41 870
David Orr Germany 14 275 0.7× 257 0.8× 98 0.3× 132 0.5× 170 1.4× 21 727
Ellen Z. Baum United States 19 127 0.3× 501 1.5× 203 0.7× 27 0.1× 211 1.8× 26 997
Werner Huber Switzerland 14 277 0.7× 253 0.8× 229 0.8× 242 1.0× 220 1.8× 22 1.2k
Karine Alvarez France 15 652 1.8× 518 1.6× 153 0.5× 183 0.7× 101 0.8× 46 1.3k

Countries citing papers authored by Hsu‐Tso Ho

Since Specialization
Citations

This map shows the geographic impact of Hsu‐Tso Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsu‐Tso Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsu‐Tso Ho more than expected).

Fields of papers citing papers by Hsu‐Tso Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsu‐Tso Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsu‐Tso Ho. The network helps show where Hsu‐Tso Ho may publish in the future.

Co-authorship network of co-authors of Hsu‐Tso Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Hsu‐Tso Ho. A scholar is included among the top collaborators of Hsu‐Tso Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsu‐Tso Ho. Hsu‐Tso Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wang, Tao, Zhongxing Zhang, Zhiwei Yin, et al.. (2018). Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir. Journal of Medicinal Chemistry. 61(14). 6308–6327. 38 indexed citations
2.
Christensen, Erik D., Mouied Alashari, Hilary Coon, et al.. (2016). Sudden infant death “syndrome”—Insights and future directions from a Utah population database analysis. American Journal of Medical Genetics Part A. 173(1). 177–182. 5 indexed citations
3.
Zhou, Nannan, Fan Li, Hsu‐Tso Ho, et al.. (2010). Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodies. Virology. 402(2). 256–261. 16 indexed citations
4.
Ho, Hsu‐Tso, Fan Li, Beata Nowicka-Sans, et al.. (2006). Envelope Conformational Changes Induced by Human Immunodeficiency Virus Type 1 Attachment Inhibitors Prevent CD4 Binding and Downstream Entry Events. Journal of Virology. 80(8). 4017–4025. 85 indexed citations
5.
Bronson, Joanne J., Kenneth DenBleyker, Paul Falk, et al.. (2003). Discovery of the first antibacterial small molecule inhibitors of MurB. Bioorganic & Medicinal Chemistry Letters. 13(5). 873–875. 76 indexed citations
6.
Guo, Qi, Hsu‐Tso Ho, Ira B. Dicker, et al.. (2003). Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions. Journal of Virology. 77(19). 10528–10536. 130 indexed citations
7.
Bronson, Joanne J., Stanley V. D’Andrea, Milind Deshpande, et al.. (2000). 4-Thiazolidinones: novel inhibitors of the bacterial enzyme murB. Bioorganic & Medicinal Chemistry Letters. 10(8). 715–717. 201 indexed citations
8.
Ho, Hsu‐Tso, et al.. (2000). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Expert Opinion on Investigational Drugs. 9(12). 2945–2972. 79 indexed citations
9.
Walsh, Ann W., Paul Falk, Jane A. Thanassi, et al.. (1999). Comparison of the d -Glutamate-Adding Enzymes from Selected Gram-Positive and Gram-Negative Bacteria. Journal of Bacteriology. 181(17). 5395–5401. 36 indexed citations
11.
Jin, Haiyong, Robert Fairman, James G. Robertson, et al.. (1996). Structural Studies of Escherichia coli UDP-N-Acetylmuramate:l-Alanine Ligase. Biochemistry. 35(5). 1423–1431. 29 indexed citations
12.
Yanchunas, Joseph, et al.. (1995). Steady-State Kinetic Mechanism of Escherichia coli UDP-N-Acetylenolpyruvylglucosamine Reductase. Biochemistry. 34(16). 5390–5402. 33 indexed citations
13.
Ho, Hsu‐Tso, et al.. (1992). Cellular Metabolism and Enzymatic Phosphorylation of 9- (2-Phosphonylmethoxyethyl) Guanine (PMEG),a Potent Antiviral Agent. Advances in experimental medicine and biology. 312. 159–166. 13 indexed citations
14.
Zhou, Zhu, Hsu‐Tso Ho, Michael J. M. Hitchcock, & Jean‐Pierre Sommadossi. (1990). Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) in human peripheral blood mononuclear cells. Biochemical Pharmacology. 39(9). R15–R19. 33 indexed citations
15.
Bronson, Joanne J., Hsu‐Tso Ho, Hilde De Boeck, et al.. (1990). Biochemical Pharmacology of Acyclic Nucleotide Analogues. Annals of the New York Academy of Sciences. 616(1). 398–407. 34 indexed citations
16.
Frey, Perry A., John P. Richard, Hsu‐Tso Ho, et al.. (1982). [14] Stereochemistry of selected phosphotransferases and nucleotidyltransferases. Methods in enzymology on CD-ROM/Methods in enzymology. 87. 213–235. 26 indexed citations
17.
Richard, John P., Hsu‐Tso Ho, & Perry A. Frey. (1978). Synthesis of nucleoside [18O]pyrophosphorothioates with chiral [18O]phosphorothioate groups of known configuration. Stereochemical orientations of enzymic phosphorylations of chiral [18O]phosphorothioates. Journal of the American Chemical Society. 100(24). 7756–7757. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026